Envoy Medical (COCH) Liabilities and Shareholders Equity (2020 - 2026)

Envoy Medical's Liabilities and Shareholders Equity history runs 7 years deep, the most recent figure standing at $29.8 million for Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity rose 187.16% year-over-year to $29.8 million; the TTM figure through Mar 2026 stood at $56.5 million (up 48.36% YoY), while the FY2025 annual figure was $8.6 million, down 25.83% from the prior year.
• Liabilities and Shareholders Equity came in at $29.8 million for Q1 2026 at Envoy Medical, up from $8.6 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $427.8 million in Q3 2022 to a low of $2.6 million in Q4 2022.
• A 5-year average of $88.7 million and a median of $10.4 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity slumped 99.4% in 2022 and jumped 223.59% in 2023, its largest moves.
• Envoy Medical's Liabilities and Shareholders Equity stood at $2.6 million in 2022, then surged by 223.59% to $8.3 million in 2023, then jumped by 39.5% to $11.5 million in 2024, then decreased by 25.83% to $8.6 million in 2025, then jumped by 248.47% to $29.8 million in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $29.8 million, $8.6 million, and $8.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison